{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:18:12Z","timestamp":1790961492315,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"am","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.gofs.2020.01.012","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:41:32Z","timestamp":1580229692000},"page":"239-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF \u2014\u00a0Aspects \u00e9pid\u00e9miologiques et facteurs de risque"],"prefix":"10.1016","volume":"48","author":[{"given":"L.","family":"Ouldamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bendifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.gofs.2020.01.012_bib0230","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.humpath.2004.03.003","article-title":"Borderline ovarian tumors: key points and workshop summary","volume":"35","author":"Silverberg","year":"2004","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.012_bib0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0240","first-page":"228","article-title":"Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential)","volume":"69","author":"Scully","year":"1982","journal-title":"Bull Cancer (Paris)"},{"issue":"9","key":"10.1016\/j.gofs.2020.01.012_bib0245","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/PAS.0000000000000693","article-title":"Low-grade serous carcinoma of the ovary: clinicopathologic analysis of 52\u00a0invasive cases and identification of a possible noninvasive intermediate lesion","volume":"40","author":"Ahn","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/PGP.0000000000000135","article-title":"Low-grade serous tumors of ovary","volume":"33","author":"Bell","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.gofs.2020.01.012_bib0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2016.11.011","article-title":"Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population","volume":"96","author":"Nasioudis","year":"2017","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0260","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpag.2017.09.001","article-title":"Borderline ovarian tumor in the pediatric and adolescent population: a case series and literature review","volume":"31","author":"Childress","year":"2018","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2017.11.024","article-title":"Risk of borderline ovarian tumors among women with benign ovarian tumors: a cohort study","volume":"148","author":"Guleria","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0270","first-page":"665","article-title":"Epidemiologic features of borderline ovarian tumors in California: a population-based study","volume":"24","author":"Morris","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/aogs.12846","article-title":"Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960\u20132007","volume":"95","author":"Kalapotharakos","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"10.1016\/j.gofs.2020.01.012_bib0280","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/01443615.2018.1441815","article-title":"Concomitant endometriosis in malignant and borderline ovarian tumours","volume":"38","author":"Oral","year":"2018","journal-title":"J Obstet Gynaecol J Inst Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0285","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.gofs.2020.01.012_bib0290","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/humrep\/det340","article-title":"Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis","volume":"28","author":"Buis","year":"2013","journal-title":"Hum Reprod Oxf Engl"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.012_bib0295","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/1055-9965.EPI-18-0503","article-title":"Borderline ovarian tumors share familial risks with themselves and invasive cancers","volume":"27","author":"Zheng","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13\u00a0case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0305","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.012_bib0310","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.2016.418","article-title":"Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300,000\u00a0Norwegian women","volume":"116","author":"Licaj","year":"2017","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0315","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/cam4.590","article-title":"Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012","volume":"5","author":"Licaj","year":"2016","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.012_bib0320","first-page":"989","article-title":"Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21\u00a0case-control studies","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.gofs.2020.01.012_bib0325","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S1470-2045(12)70322-4","article-title":"Ovarian cancer and smoking: individual participant meta-analysis including 28,114\u00a0women with ovarian cancer from 51\u00a0epidemiological studies","volume":"13","author":"Beral","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0330","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ijc.23108","article-title":"Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer","volume":"122","author":"Gram","year":"2008","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.012_bib0335","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol Stockh Swed"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0340","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/gyno.2001.6451","article-title":"Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study","volume":"83","author":"Riman","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.012_bib0345","first-page":"821","article-title":"Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study","volume":"17","author":"Huusom","year":"2006","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0350","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2017.01.002","article-title":"Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: a nationwide case-control study","volume":"144","author":"Rasmussen","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.012_bib0355","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ygyno.2017.07.138","article-title":"Systematic review: tumor-associated antigen autoantibodies and ovarian cancer early detection","volume":"147","author":"Fortner","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.012_bib0360","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00404-013-2784-1","article-title":"Ovarian epithelial tumors and reproductive factors: a systematic review","volume":"287","author":"Sch\u00fcler","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0365","first-page":"113","article-title":"Hormone therapy and ovarian borderline tumors: a national cohort study","volume":"23","author":"M\u00f8rch","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.012_bib0370","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.23509","article-title":"Body size and risk of epithelial ovarian and related cancers: a population-based case-control study","volume":"123","author":"Olsen","year":"2008","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0375","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ije\/dyw158","article-title":"Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study","volume":"45","author":"Dixon","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.gofs.2020.01.012_bib0380","first-page":"595","article-title":"Relationship of ovarian neoplasms and body mass index","volume":"50","author":"Wright","year":"2005","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.012_bib0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/ERC-12-0395","article-title":"Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium","volume":"20","author":"Olsen","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"10.1016\/j.gofs.2020.01.012_bib0390","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3109\/0284186X.2014.1001035","article-title":"Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: results from a Danish case-control study","volume":"54","author":"Gosvig","year":"2015","journal-title":"Acta Oncol Stockh Swed"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0395","first-page":"359","article-title":"Coffee, tea and caffeine and risk of epithelial ovarian cancer","volume":"15","author":"Jordan","year":"2004","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2011.03.021","article-title":"Accuracy of frozen section diagnosis of borderline ovarian tumors","volume":"122","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.012_bib0405","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1055-9965.EPI-10-0752","article-title":"Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study","volume":"20","author":"Hedelin","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.012_bib0410","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.canep.2014.07.011","article-title":"Dietary fat intake and risk of epithelial ovarian cancer in the European prospective investigation into cancer and nutrition","volume":"38","author":"Merritt","year":"2014","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.012_bib0415","first-page":"485","article-title":"Recreational physical activity and risk of epithelial ovarian cancer","volume":"21","author":"Rossing","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.012_bib0420","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1007\/s13277-014-2385-z","article-title":"Nonoccupational physical activity and risk of ovarian cancer: a meta-analysis","volume":"35","author":"Zhong","year":"2014","journal-title":"Tumour Biol J Int Soc Oncodev Biol Med"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0425","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/EDE.0000000000000434","article-title":"The association between talc use and ovarian cancer: a retrospective case-control study in two US states","volume":"27","author":"Cramer","year":"2016","journal-title":"Epidemiol Camb Mass"},{"issue":"12","key":"10.1016\/j.gofs.2020.01.012_bib0430","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1093\/humrep\/der322","article-title":"Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort","volume":"26","author":"van Leeuwen","year":"2011","journal-title":"Hum Reprod Oxf Engl"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.012_bib0435","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2013.01.027","article-title":"In vitro fertilization is associated with an increased risk of borderline ovarian tumours","volume":"129","author":"Stewart","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.012_bib0440","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/humrep\/deu297","article-title":"Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study","volume":"30","author":"Bj\u00f8rnholt","year":"2015","journal-title":"Hum Reprod Oxf Engl"},{"issue":"22","key":"10.1016\/j.gofs.2020.01.012_bib0445","first-page":"8042","article-title":"Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors","volume":"22","author":"Del Pup","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.012_bib0225","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2018.09.022","article-title":"Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark","volume":"151","author":"Hannibal","year":"2018","journal-title":"Gynecol Oncol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:39:59Z","timestamp":1762853999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718920300325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2468718920300325"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.012","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumeurs fronti\u00e8res de l\u2019ovaire. Recommandations pour la pratique clinique du CNGOF \u2014\u00a0Aspects \u00e9pid\u00e9miologiques et facteurs de risque","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}